title: [Glucose renal excretion as diabetes treatment: From an old diagnostic method to a new way of treatment].
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitari Vall d'Hebron, Barcelona, España. Electronic address: bdalama@vhebron.net.
authors.forename: Belén
authors.initials: B
authors.lastname: Dalama
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitari Vall d'Hebron, Barcelona, España.
authors.forename: Betina
authors.initials: B
authors.lastname: Biagetti
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitari Vall d'Hebron, Barcelona, España.
authors.forename: Jordi
authors.initials: J
authors.lastname: Mesa
mesh_terms: D001559:Benzhydryl Compounds / Q000494:pharmacology / Q000627:therapeutic use; D015415:Biomarkers / Q000652:urine; D000068896:Canagliflozin / Q000494:pharmacology / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy* / Q000652:urine; D005960:Glucosides / Q000494:pharmacology / Q000627:therapeutic use; D006029:Glycosuria / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D065667:Renal Elimination / Q000187:drug effects*; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001559:Benzhydryl Compounds; D015415:Biomarkers; D005960:Glucosides; D007004:Hypoglycemic Agents; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D000068896:Canagliflozin; C529054:dapagliflozin; C570240:empagliflozin